On the stock market since 2024, it operates in the world of health and science. It has 84 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
Debt is low and cash is strong; the finances stand solid.
Clearly below the class average.
Clearly below the class average.
The stock has been running stronger than the market lately.
Growth: Sales growth trails the sector average.
Business Quality: Profit power and business quality trail similar companies in the sector.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Profit per Sale: The profit kept from each sale is thin.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
There is $490.5M in the vault; even if every debt were paid off, $479.1M would remain.
The average analyst price target is $62.80 — 31% above today’s price.
A loss of $111.5M against $0 in annual sales.
Over the last 12 months, executives reported 67 sells against just 17 buys. Not an alarm bell by itself, but a number worth watching.
On our five-subject report card, RAPP sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: RAPP is a high-risk stock — not yet profitable, and its future rides on its product catching on.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.
Analysts’ average target sits above today’s price, yet the valuation grade (45/100) says the stock isn’t cheap.